View Item 

Show simple item record

Variation in prostate cancer treatment and spending among Medicare shared savings program accountable care organizations
dc.contributor.authorModi, Parth K.
dc.contributor.authorKaufman, Samuel R.
dc.contributor.authorBorza, Tudor
dc.contributor.authorYan, Phyllis
dc.contributor.authorMiller, David C.
dc.contributor.authorSkolarus, Ted A.
dc.contributor.authorHollingsworth, John M.
dc.contributor.authorNorton, Edward C.
dc.contributor.authorShahinian, Vahakn B.
dc.contributor.authorHollenbeck, Brent K.
dc.date.accessioned2018-09-04T20:09:14Z
dc.date.available2019-09-04T20:15:39Zen
dc.date.issued2018-08
dc.identifier.citationModi, Parth K.; Kaufman, Samuel R.; Borza, Tudor; Yan, Phyllis; Miller, David C.; Skolarus, Ted A.; Hollingsworth, John M.; Norton, Edward C.; Shahinian, Vahakn B.; Hollenbeck, Brent K. (2018). "Variation in prostate cancer treatment and spending among Medicare shared savings program accountable care organizations." Cancer 124(16): 3364-3371.
dc.identifier.issn0008-543X
dc.identifier.issn1097-0142
dc.identifier.urihttps://hdl.handle.net/2027.42/145563
dc.publisherWiley Periodicals, Inc.
dc.subject.otheraccountable care organizations
dc.subject.otherovertreatment
dc.subject.otherprostate cancer
dc.subject.otherspending
dc.subject.othertreatment
dc.titleVariation in prostate cancer treatment and spending among Medicare shared savings program accountable care organizations
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelOncology and Hematology
dc.subject.hlbsecondlevelPublic Health
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/145563/1/cncr31573.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/145563/2/cncr31573_am.pdf
dc.identifier.doi10.1002/cncr.31573
dc.identifier.sourceCancer
dc.identifier.citedreferenceNational Comprehensive Cancer Network. NCCN guidelines for patients: prostate cancer. https://www.nccn.org/patients/guidelines/prostate/index.html. Accessed January 28, 2018.
dc.identifier.citedreferenceSiegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018; 68: 7 ‐ 30.
dc.identifier.citedreferenceStokes ME, Ishak J, Proskorovsky I, Black LK, Huang Y. Lifetime economic burden of prostate cancer. BMC Health Serv Res. 2011; 11: 349.
dc.identifier.citedreferenceMariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010‐2020. J Natl Cancer Inst. 2011; 103: 117 ‐ 128.
dc.identifier.citedreferenceRoehrig C, Miller G, Lake C, Bryant J. National health spending by medical condition, 1996‐2005. Health Aff (Millwood). 2009; 28: w358 ‐ 367.
dc.identifier.citedreferenceBill‐Axelson A, Holmberg L, Garmo H, et al. Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med. 2014; 370: 932 ‐ 942.
dc.identifier.citedreferenceZavaski ME, Meyer CP, Sammon JD, et al. Differences in prostate‐specific antigen testing among urologists and primary care physicians following the 2012 USPSTF recommendations. JAMA Intern Med. 2016; 176: 546 ‐ 547.
dc.identifier.citedreferenceBarocas DA, Mallin K, Graves AJ, et al. Effect of the USPSTF grade D recommendation against screening for prostate cancer on incident prostate cancer diagnoses in the United States. J Urol. 2015; 194: 1587 ‐ 1593.
dc.identifier.citedreferenceBorza T, Kaufman SR, Shahinian VB, et al. Sharp decline in prostate cancer treatment among men in the general population, but not among diagnosed men. Health Aff (Millwood). 2017; 36: 108 ‐ 115.
dc.identifier.citedreferenceFisher ES, Shortell SM. Accountable care organizations: accountable for what, to whom, and how. JAMA. 2010; 304: 1715 ‐ 1716.
dc.identifier.citedreferenceFisher ES, McClellan MB, Bertko J, et al. Fostering accountable health care: moving forward in Medicare. Health Aff (Millwood). 2009; 28: w219 ‐ w231.
dc.identifier.citedreferenceHamdy FC, Donovan JL, Lane JA, et al. 10‐year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med. 2016; 375: 1415 ‐ 1424.
dc.identifier.citedreferenceBorza T, Kaufman SR, Yan P, et al. Early effect of Medicare Shared Savings Program accountable care organization participation on prostate cancer care. Cancer. 2018; 124: 563 ‐ 570.
dc.identifier.citedreferenceResnick MJ, Graves AJ, Buntin MB, Richards MR, Penson DF. Surgeon participation in early accountable care organizations. Ann Surg. 2018; 267: 401 ‐ 407.
dc.identifier.citedreferenceHawken SR, Herrel LA, Ellimoottil C, Ye Z, Hollenbeck BK, Miller DC. Urologist participation in Medicare Shared Savings Program accountable care organizations (ACOs). Urology. 2016; 90: 76 ‐ 80.
dc.identifier.citedreferenceHollenbeck BK, Bierlein MJ, Kaufman SR, et al. Implications of evolving delivery system reforms for prostate cancer care. Am J Manag Care. 2016; 22: 569 ‐ 575.
dc.identifier.citedreferenceKlabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000; 53: 1258 ‐ 1267.
dc.identifier.citedreferenceCenters for Medicare and Medicaid Services. Medicare Shared Savings Program shared savings and losses and assignment methodology, version 3. https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/sharedsavingsprogram/Downloads/Shared-Savings-Losses-Assignment-Spec-V5.pdf. Accessed January 28, 2018.
dc.identifier.citedreferenceShahinian VB, Kuo YF, Freeman JL, Goodwin JS. Determinants of androgen deprivation therapy use for prostate cancer: role of the urologist. J Natl Cancer Inst. 2006; 98: 839 ‐ 845.
dc.identifier.citedreferenceJacobs BL, Zhang Y, Schroeck FR, et al. Use of advanced treatment technologies among men at low risk of dying from prostate cancer. JAMA. 2013; 309: 2587 ‐ 2595.
dc.identifier.citedreferenceDiez Roux AV, Merkin SS, Arnett D, et al. Neighborhood of residence and incidence of coronary heart disease. N Engl J Med. 2001; 345: 99 ‐ 106.
dc.identifier.citedreferenceDimick JB, Ghaferi AA, Osborne NH, Ko CY, Hall BL. Reliability adjustment for reporting hospital outcomes with surgery. Ann Surg. 2012; 255: 703 ‐ 707.
dc.identifier.citedreferenceDimick JB, Staiger DO, Birkmeyer JD. Ranking hospitals on surgical mortality: the importance of reliability adjustment. Health Serv Res. 2010; 45 ( 6 pt 1 ): 1614 ‐ 1629.
dc.identifier.citedreferenceAlbertsen PC, Moore DF, Shih W, Lin Y, Li H, Lu‐Yao GL. Impact of comorbidity on survival among men with localized prostate cancer. J Clin Oncol. 2011; 29: 1335 ‐ 1341.
dc.identifier.citedreferenceDaskivich TJ, Fan KH, Koyama T, et al. Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population‐based cohort of men with prostate cancer. Ann Intern Med. 2013; 158: 709 ‐ 717.
dc.identifier.citedreferenceOffice of Inspector General. Medicare Shared Savings Program accountable care organizations have shown potential for reducing spending and improving quality (OEI‐02‐15‐00450). https://oig.hhs.gov/oei/reports/oei-02-15-00450.asp.
dc.identifier.citedreferenceDupree JM, Patel K, Singer SJ, et al. Attention to surgeons and surgical care is largely missing from early Medicare accountable care organizations. Health Aff (Millwood). 2014; 33: 972 ‐ 979.
dc.identifier.citedreferenceRitch CR, Graves AJ, Keegan KA, et al. Increasing use of observation among men at low risk for prostate cancer mortality. J Urol. 2015; 193: 801 ‐ 806.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
cncr31573.pdf
Size:
298.9KB
Format:
PDF
View/Open
Name:
cncr31573_am.pdf
Size:
555.8KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.